TROPiCS-03: A phase II open-label study of sacituzumab govitecan (SG) in patients with metastatic solid tumors Meeting Abstract


Authors: Saxena, A.; Michel, L. S.; Hong, Q.; Hilsinger, K.; Kanwal, C.; Pichardo, C.; Goswami, T.; Santin, A.
Abstract Title: TROPiCS-03: A phase II open-label study of sacituzumab govitecan (SG) in patients with metastatic solid tumors
Meeting Title: 56th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 38
Issue: 15 Suppl.
Meeting Dates: 2020 May 29-31
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2020-05-20
Language: English
ACCESSION: WOS:000560368309091
PROVIDER: wos
DOI: 10.1200/JCO.2020.38.15_suppl.TPS3648
Notes: Meeting Abstract: TPS3648 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Loren Michel
    61 Michel